Endo USA, Inc. recalls
10 federal recalls on file, showing the 5 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Endo USA, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-05-20FDA-DrugClass IIEndo USA buprenorphine injection recalled for particulate matter
Endo USA is recalling certain batches of buprenorphine hydrochloride 0.3 mg/mL injection due to the presence of particulate matter identified as buprenorphine free base in the vials. The affected lots are 84132 (expiration 02/28/2027) and 87693 (expiration 03/31/2027). No injuries have been reported.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-128-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-11-05FDA-DrugClass IIIEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- 2025-10-22FDA-DrugClass IIIEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Get the week's recalls, including Endo USA, Inc.
Free weekly digest — every federal recall affecting your household, Endo USA, Inc. included when it comes up. Track Endo USA, Inc. specifically with Always-on.